Detailed FundamentalsSingle-page fundamentals layout — broad valuation, growth, profitability, health, competitors, top funds & analyst detail.
Price chartUnavailable
Loading price history...
52-Week Range
Trailing twelve months
$45.80$61.70
1-Month Range
Month up 8.7%
$46.27$51.54
Daily Price Range
Day down -1.8%
$49.79$50.36
Volume
vs 5M avg
1M5M avg
Profile
Identity and capital structure
SectorUnclassified
IndustryCommon Stock
Market Cap$100.4B
Short % of Float—
Employees—
Sales—
Shares Outstanding1,995,427,435
IPO Date—
Last Reported Qtr.—
Next Qtr. Report—
Headquarters—
Homepagewww.gsk.com
GSK plc — is a public issuer in the Vantage universe..
Warnings
1 signal
Live
- No material red flags detected in fundamental screen
Scores
0–100 · higher is better except where noted · Insider Sent: directional buy ratio (excl. gifts/grants)
Value
—
Growth
—
Quality
—
Sentiment
—
Insider Sent.
—
Piotroski F
—
Altman Z
—
Consensus rating unavailable — no analyst coverage on file for GSK.
Price targets unavailable — no 12-month targets on file for GSK.
Valuation Engine
DCF Intrinsic Valuation Model
Run an interactive 5-year Discounted Cash Flow valuation on GSK, calculate Margin of Safety, and stress-test WACC discount hurdles.
RetrievedQuote: Live · Insiders: Live · Fundamentals/Benchmarks: Curated · Vantage Composite · 1 warnings surfacedNov 11, 2026, 6:51 PM UTC